Back to Trades
Total Value
$0
Filing Date
Jun 18, 2026
1 transactions
Trade Summary
On Jun 15, 2026, Innovative Cellular Therapeutics Holdings Ltd, Insider, reported $0 of Lyell Immunopharma, Inc. (LYEL) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Lyell Immunopharma, Inc.
- Ticker Symbol
- LYEL
- CIK
- 0001806952
Insider Information
- Role
- Insider
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 15, 2026
- Accession Number
- 0001140361-26-025796
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | 66,500 | — | Other | — |
Want live alerts when Innovative Cellular Therapeutics Holdings Ltd trades again?
Download Insider Trades to track LYEL, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of Common Stock transferred by the Reporting Person to LifeSci Advisors, LLC as broker commission in connection with the Upfront Payment (as such term is defined in the License Agreement, dated November 6, 2025, between the Issuer and the Reporting Person). The transaction was a transfer of securities for no cash consideration to the Reporting Person and is reported under transaction code J.
- (F2)Reflects 3,000,000 shares of Common Stock beneficially owned by the Reporting Person immediately prior to the reported transaction, less the 66,500 shares transferred. All shares are held directly and registered in the name of the Reporting Person.